⌘K

Home/Filings/4/0000914190-14-000070

4//SEC Filing

Arno Therapeutics, Inc 4

Accession 0000914190-14-000070

CIK 0001195116operating

View on SEC.gov Company Profile

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 8:17 PM ET

Size

5.3 KB

Accession

0000914190-14-000070

Insider Transaction Report

Form 4

Period: 2014-02-24

Arno Therapeutics, IncARNI

KENYON LAWRENCE A

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2014-02-24+223,445→ 223,445 total
Exercise: $2.23Exp: 2024-02-24→ Common Stock (223,445 underlying)

Footnotes (1)

[F1]Vests 25% on first anniversary date and thereafter will vest in 24 equal monthly installments.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Arno Therapeutics, Inc

CIK 0001195116

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001195116

Filing Metadata

Form type: 4
Filed: Feb 25, 7:00 PM ET
Accepted: Feb 26, 8:17 PM ET
Size: 5.3 KB

View on SEC.gov